DeSantis Robert - Sep 10, 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Strategy & Corp Op
Signature
By: Donna Spinola For: DeSantis, Robert
Stock symbol
ISRG
Transactions as of
Sep 10, 2024
Transactions value $
-$50,092
Form type
4
Date filed
9/10/2024, 07:07 PM
Previous filing
Aug 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $36.3K +119 +2.16% $304.67 5.63K Sep 10, 2024 Direct F1
transaction ISRG Common Stock Sale -$56.8K -119 -2.12% $477.50 5.51K Sep 10, 2024 Direct F1
transaction ISRG Common Stock Options Exercise $27.3K +119 +2.16% $229.39 5.63K Sep 10, 2024 Direct F1
transaction ISRG Common Stock Sale -$56.8K -119 -2.12% $477.50 5.51K Sep 10, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -119 -3.31% $0.00 3.47K Sep 10, 2024 Common Stock 119 $229.39 Direct F1, F2
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -119 -3.31% $0.00 3.47K Sep 10, 2024 Common Stock 119 $304.67 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.
F2 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
F3 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.